Perspectives on Outsourcing

Jan 01, 2012
BioPharm International
Some recent private-equity buyouts of CROs show both the upside and downside for investors.
Oct 01, 2011
BioPharm International
CROs that have made big acquisitions could be outmaneuvered by evolving sourcing models.
Sep 01, 2011
BioPharm International
The EU debt crisis portends of possible negative repercussions for the dose CMO industry.
Aug 01, 2011
BioPharm International
China rises to the top as a destination for international outsourcing.
Jul 01, 2011
BioPharm International
Better strategies and practices in sourcing and procurement can contribute to the bottom line.
Jun 01, 2011
BioPharm International
A recent industry survey shows keen interest in improving bioreactors and cell-culture media.
May 01, 2011
BioPharm International
Addressing supply-chain challenges.
Apr 01, 2011
BioPharm International
Mergers and acquisitions expected to increase, as big companies bolster piplines by acquiring smaller biotech companies.
Mar 01, 2011
BioPharm International
Indian manufacturers are not now a threat to Western CMOs, but may be long term.
Jan 01, 2011
BioPharm International
CDMOs and CMOs face weak economic recovery, consolidation, and globalization.
native1_300x100
lorem ipsum